InvestorsHub Logo
icon url

louieblouie

10/05/20 4:30 PM

#303335 RE: iryokabu #303332

thats really screwed up. Stupid FDA should have gone forward with the rule if they are truly concerned about safety. Clearly this shows they are not.
icon url

bigkahuna2006

10/05/20 4:46 PM

#303343 RE: iryokabu #303332

"It runs contrary to the goals of the generic approval process, which requires generic medicines to have the same label as the reference listed drug," Gottlieb and Janet Woodcock, Director of FDA's Center for Drug Evaluation and Research, said.

However, Gottlieb and Woodcock acknowledged that some generic drug labels need updates. As such, the officials announced that FDA will launch a new program for updating the labels on certain generic cancer drugs. The officials also said FDA is working with Congress on the agency's potential need for new authority or resources to address outdated generic drug labels."

icon url

Bolio98

10/05/20 5:03 PM

#303351 RE: iryokabu #303332

FDA was not involved in the GSK Teva case and they would not be involved in the AMRN vs generic case either.